Filter News
Area of Research
News Topics
- (-) Biomedical (3)
- (-) Machine Learning (1)
- (-) Nuclear Energy (4)
- 3-D Printing/Advanced Manufacturing (4)
- Artificial Intelligence (1)
- Bioenergy (4)
- Clean Water (1)
- Composites (3)
- Computer Science (6)
- Cybersecurity (2)
- Energy Storage (4)
- Environment (6)
- Grid (1)
- Isotopes (5)
- Materials Science (10)
- Microscopy (3)
- Nanotechnology (6)
- Neutron Science (13)
- Physics (3)
- Polymers (2)
- Quantum Science (3)
- Sustainable Energy (3)
- Transportation (4)
Media Contacts
ORNL computer scientist Catherine Schuman returned to her alma mater, Harriman High School, to lead Hour of Code activities and talk to students about her job as a researcher.
Six new nuclear reactor technologies are set to deploy for commercial use between 2030 and 2040. Called Generation IV nuclear reactors, they will operate with improved performance at dramatically higher temperatures than today’s reactors.
Scientists have demonstrated a new bio-inspired material for an eco-friendly and cost-effective approach to recovering uranium from seawater.
Researchers at the Department of Energy’s Oak Ridge National Laboratory, Pacific Northwest National Laboratory and Washington State University teamed up to investigate the complex dynamics of low-water liquids that challenge nuclear waste processing at federal cleanup sites.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
“Made in the USA.” That can now be said of the radioactive isotope molybdenum-99 (Mo-99), last made in the United States in the late 1980s. Its short-lived decay product, technetium-99m (Tc-99m), is the most widely used radioisotope in medical diagnostic imaging. Tc-99m is best known ...